Walked-all-overya!

Pfizer Continues to Fall Further

Anyone who follows the company at all can discern that there are difficult times still ahead.

That said, it is time for the analysts, reporters and others to look at companies through a more appropriate lens - that is, the long term value and prospect of the business.

Many troubles facing businesses today are the result of trying to appease the short term. Issuing stock is a way for a company to create LONG TERM capital to service the business. The best value a company can deliver to its shareholders is to create a sustainable company that will be around for the long haul to pay dividends, etc.

This short term, gimme cash/returns NOW nonsense is an absolute poison to business. The pharma business - developing drugs - is a very long cycle. Start running, and evaluating, pharma companies through that lens.